A prosecutor’s office in charge of investigating the misuse of public funds is probing the Arab Company for Drug Industries and Medical Appliances (ACDIMA) amid allegations it engaged in monopolistic practices that resulted in a penicillin shortage in the local market, Al Masry Al Youm reports. The Health Ministry is reportedly accusing ACDIMA’s former president, Medhat Shaarawi, of halting an incoming shipment of penicillin and rerouting the shipment through a company owned by one of his family members. The ministry alleges that was behind the penicillin shortage citizens began complaining about earlier this month. Shaarawi has denied the allegations.
More from Enterprise
Banks threaten to look beyond London as windfall tax talk grows
International lenders say more tax could tip the balance as…
Granite is about to test whether Egypt’s funds still need administrators
The asset manager and blockchain builder Tarmiiz have entered the…
Gulf stock exchanges are growing in importance, but they’re still a long way from becoming capital market hubs -Fitch
The diagnosis lands in a year when UAE and Saudi…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…